FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management
The FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that...
top of page
Browse by category
Search
Apollo’s ESG and REVISE Systems approved by FDA
Apollo Endosurgery has been granted marketing authorisation for its ESG, ESG Sx, REVISE and REVISE Sx through the FDA’s De Novo...
Spatz Medical’s first adjustable gastric balloon, the Spatz3 Gastric Balloon, approved in US
The FDA has approved the Spatz Medical’s Spatz3 Gastric Balloon, the first adjustable gastric balloon system, to aid in weight loss for...
FDA approves Novo Nordisk’s Wegovy (semaglutide 2.4 mg) for weight management
The FDA has approved Novo Nordisk’s Wegovy (the brand name for once-weekly semaglutide 2.4mg injection in the US) for chronic weight...
Browse by tag
bottom of page